Advertisement

Severe attacks - Biotech, Pharma and Life Science Channel

10:38 EDT 21st May 2013 | BioPortfolio

PubMed Articles [ 4332 Associated PubMed Articles listed on BioPortfolio]

A Secure Smart-Card Based Authentication and Key Agreement Scheme for Telecare Medicine Information Systems.

A smart-card based authentication scheme for telecare medicine information systems enables patients, doctors, nurses, health visitors and the medicine information systems to establish a secure communi...

A Secure and Efficient Password-Based User Authentication Scheme Using Smart Cards for the Integrated EPR Information System.

The integrated EPR information system supports convenient and rapid e-medicine services. A secure and efficient authentication scheme for the integrated EPR information system provides safeguarding pa...

A Secure and Efficient Uniqueness-and-Anonymity-Preserving Remote User Authentication Scheme for Connected Health Care.

Connected health care has several applications including telecare medicine information system, personally controlled health records system, and patient monitoring. In such applications, user authentic...

Identifying risk factors for symptoms of severe trichinellosis - A case study of 143 infected persons in Brasov, Romania 2001-2008.

The presence of the parasite Trichinella spiralis in humans does not always manifest itself with obvious clinical symptoms; the clinical manifestations of trichinellosis are polymorphic and can cause...

Mild bleeding diathesis in a 62-year-old woman with hereditary thrombocytopenia.

A 62-year-old woman presented with severe, isolated thrombocytopenia. Due to the positive family history and normal thrombocyte morphology ANKRD26-associated thrombocytopenia 2 (THC2) was suspected. T...

Computational Study on the Attack of (.) OH Radicals on Aromatic Amino Acids.

The attack of hydroxyl radicals on aromatic amino acid side chains, namely phenylalanine, tyrosine, and tryptophan, have been studied by using density functional theory. Two reaction mechanisms were c...

Inhaled Glycopyrronium Bromide: A Review of its Use in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease.

Inhaled glycopyrronium bromide (Seebri(®) Breezhaler(®) capsules; NVA237) is a once-daily, long-acting muscarinic receptor antagonist (LAMA) that is approved in several countries, including the EU,...

Mood disturbance in glioma patients.

Patients diagnosed with primary brain tumors such as glioma experience psychological distress throughout the illness trajectory. Determining which patient characteristics are associated with more seve...

Correction of hypocalcemia allows optimal recruitment of FGF-23-dependent phosphaturic mechanisms in acute hyperphosphatemia post-phosphate enema.

Both parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) are phosphaturic hormones. These hormones should increase in response to phosphate excess. However, they also regulate serum calc...

Cerebrospinal Fluid and Plasma Oxidative Stress Biomarkers in Different Clinical Phenotypes of Neuroinflammatory Acute Attacks. Conceptual Accession: From Fundamental to Clinic.

Oxidative stress is revealed as the main contributor in the pathophysiology of neuroinflammation. Analyzing plasma and cerebrospinal fluid (CSF) of patients with different clinical phenotypes of neuro...

News Articles [ 3935 Associated News Articles listed on BioPortfolio]

Regeneron, Sanofi asthma drug seen as potential game changer

(Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patie...

Women are less likely than men to receive care in trauma center after severe injury

Women are less likely than men to receive care in a trauma center after severe injury, according to a new study of almost 100,000 Canadian patients.

Grifols signs worldwide licensing agreement for Aradigm's Pulmaquin

Grifols, S.A. and Aradigm Corporation today announced the signing of an exclusive, worldwide license for Aradigm's proprietary formulations of inhaled ciprofloxacin (Pulmaquin and Lipoquin) for the tr...

Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine

PARIS and TARRYTOWN, N.Y., May 21, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the New England Journal of Medicine...

Boehringer Ingelheim Presents Phase 3 Sub-Analyses for Tiotropium Across a Range of Symptomatic Asthma Patients at ATS 2013

RIDGEFIELD, Conn., May 21, 2013 /PRNewswire/ -- Boehringer Ingelheim today announced data from Phase 2 and Phase 3 studies from the Company's ongoing clinical trial program investigating the efficacy...

Personal Injury Law Firm Announces New Informational Graphic Regarding Dog Bite Injuries

The law offices of d’Oliveira & Associates have released a dog bite infographic with information on common dog bite injuries, potentially dangerous dog breeds, and fatal dog attack statistics. (...

US Drug Watchdog Now Urges Victims Of A Transvaginal Mesh Failure With Severe Complications To Call Them For The Names Of National Caliber Women Lawyers-Get Compensated

The US Drug Watchdog does not believe a woman victim of a transvaginal mesh failure would want to share a gender specific horror story with a male attorney, so they are offering the contacts for natio...

Corporate Whistle Blower Now Urges Physicians With Proof Transvaginal Mesh Makers Knew About Failures And Continued To Sell The Product Anyway To Call Them About Rewards

The Corporate Whistle Blower Center is urging physicians, or surgeons to call them if they possess significant proof a manufacturer of a transvaginal mesh, tape or sling medical product knew about fai...

R-Tech begins enrolling patients in Phase I/II severe dry eye study

R-Tech Ueno has begun enrolling patients with severe dry eye in Phase I/II study of recombinant human serum albumin-containing ophthalmic solution (development code: RU-101) in US.

New diagnostic test for lymphatic filariasis

A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a fi...

Events [0 Results]

None

Companies [ 50 Associated Companies listed on BioPortfolio]

Aradigm Corporation and Grifols S.A.

Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of sever...

Promedior, Inc.

Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By...

Zalicus Inc

Zalicus focuses its internal drug development efforts on pain and immuno-inflammatory diseases. Our pipeline for pain includes Exalgo™ (hydromorphone HCl) extended-release ta...

AZ-TMJ

AZ-TMJ is a clinic focused on the treatment of TMJ, Severe Headaches and Sleep Apnea, all of which can be symptoms of an issue with the Temporomandibular Joint, which is where the...

CytomX Therapeutics

CytomX Therapeutics is an early stage biotechnology company developing Probodies™, or proteolytically-activated antibodies. Probodies combine the well-established power and s...

AB Science SA

Founded in 2001, AB Science is a pharmaceutical company specialising in the research, development and commercialisation of protein kinase inhibitors (PKIs), a new class of targete...

MyoPowers

MyoPowers Medical Technologies SA was founded by Dr Piergiorgio Tozzi, MD, of the University Hospital of Lausanne (CHUV), Switzerland and Professor Daniel Hayoz of the Cantonal Ho...

Arsanis, Inc

Arsanis is committed to the development of monoclonal antibody therapeutics against severe infectious diseases that cannot be controlled with currently available medical treatment...

Proximex

Based in San Jose, Calif., Proximex is the leader in event and information management for both physical and logical security markets. Transportation, defense and corporate custome...

Thrasos Innovation, Inc.

Thrasos is a private, clinical stage, bio-therapeutics Company focused on the discovery and development of targeted therapies for the prevention and treatment of severe organ fail...

Clinical Trials [ 1453 Associated Clinical Trials listed on BioPortfolio]

Pamidronate to Treat Osteogenesis Imperfecta in Children

This study will evaluate the effect of pamidronate-a drug that decreases bone resorption (breakdown)-on osteogenesis imperfecta. This is a genetic disorder of collagen, the major protein...

Progesterone for the Treatment of Traumatic Brain Injury

The ProTECT study will determine if intravenous (IV) progesterone (started within 4 hours of injury and given for a total of 96 hours), is more effective than placebo for treating victims...

A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A

This trial is conducted globally. The aim of the trial is to investigate safety, efficacy and pharmacokinetics (the exposure of the trial drug in the body) of NNC 0129-0000-1003 (N8-GP) in...

Antidepressant Treatment at an Inner City Asthma Clinic

Asthma is common with an increasing prevalence and mortality especially in low-income and minority populations. The course of asthma appears to be influenced by mood and emotions. It has b...

Research in Severe Asthma (RISA) Trial

The purpose of this study is to evaluate the safety and efficacy of the Alair System for the treatment of severe refractory asthma. This will be a multicenter, randomized controlled study...

PS-341 With Oral Temozolomide in Patients With Advanced Refractory Solid Tumors or Melanoma

Patients are asked to participate in this research because they have been diagnosed as having cancer that is not curable by any standard means including surgery or radiation therapy or oth...

Effect of Valsartan on Carotid Artery Disease

Atherosclerosis or 'hardening of the arteries' is a process that ultimately leads to the development of heart attacks, strokes, poor circulation, and death. Millions of Americans are affe...

Alemtuzumab to Treat Severe Aplastic Anemia

This study will evaluate the safety and usefulness of a new immunosuppressive drug, alemtuzumab (Campath(Registered Trademark)), in patients with severe aplastic anemia (SAA). SAA is a rar...

Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma

There is no standard treatment for the patient population being asked to participate in this study. Although one current regimen, used by some investigators, has a high rate of response co...

HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus Erythematosus

Several studies have shown that persons with systemic lupus erythematosus (SLE) have poor general health and a higher risk of heart attack and bone loss (osteoporosis) compared to the gene...

Medical and Biotech [MESH] Definitions

Leptospira Interrogans Serovar Australis

A serovar of the bacterial species LEPTOSPIRA INTERROGANS, characteristically associated with a severe zoonotic disease in humans.

Anaplasma Marginale

A species of gram-negative bacteria and causative agent of severe bovine ANAPLASMOSIS. It is the most pathogenic of the ANAPLASMA species.

Anaplasma Ovis

A species of gram-negative bacteria producing mild to severe ANAPLASMOSIS in SHEEP and GOATS, and mild or inapparent infections in DEER and CATTLE.

Vibrio Cholerae Non-o1

A strain of the VIBRIO CHOLERAE bacteria belonging to serogroup non-O1, infecting humans and other PRIMATES. It is related to VIBRIO CHOLERAE O1, but causes a disease less severe than CHOLERA. Eating raw shellfish contaminated with the bacteria results in GASTROENTERITIS.

Severe Acute Respiratory Syndrome

A viral disorder characterized by high FEVER, dry COUGH, shortness of breath (DYSPNEA) or breathing difficulties, and atypical PNEUMONIA. A virus in the genus CORONAVIRUS is the suspected agent.

Search BioPortfolio:
Advertisement
review and buy Severe attacks market research data and corporate reports here

Channels Quicklinks

Advertisement